A Glimmer of Hope for Patients with Advanced Biliary Tract Cancer
source: pixabay.com

A Glimmer of Hope for Patients with Advanced Biliary Tract Cancer

    For patients who were given a diagnosis of advanced, inoperable (unresectable) biliary tract cancer, an article appeared in Healio with some encouraging news. Gemcitabine and cisplatin drugs have…

Continue Reading A Glimmer of Hope for Patients with Advanced Biliary Tract Cancer
New Cell Therapy Approved by the FDA to Reduce Risk of Infection After Transplant
source: pixabay.com

New Cell Therapy Approved by the FDA to Reduce Risk of Infection After Transplant

  Omisirge (omidubicel) is the first allogeneic (from a donor) product for SCT that has been the recipient of FDA approval. The FDA's nod moves Omisirge into the realm of…

Continue Reading New Cell Therapy Approved by the FDA to Reduce Risk of Infection After Transplant
Study of the Week: Hydroxyurea Underused in Pediatric Sickle Cell Anemia Patients Despite Recommendations
source: pixabay.com

Study of the Week: Hydroxyurea Underused in Pediatric Sickle Cell Anemia Patients Despite Recommendations

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Hydroxyurea Underused in Pediatric Sickle Cell Anemia Patients Despite Recommendations
Glioblastoma: Current Therapies and Recent Therapeutic Advances
source: pixabay.com

Glioblastoma: Current Therapies and Recent Therapeutic Advances

Republished with permission from Personalize My Medicine, a Patient Worthy partner organization.  Written by Eleanor Doherty Glossary Antibody, Antidepressant, Antigen, Apoptosis, Astrocyte, CAR-T Cell Therapy, Atypia, Clinical Trial, CNS, Dendritic Cell Vaccine, Epidermal Growth Factor, Ex-Vivo, Glioblastoma Multiforme, Glioma, Immunotherapy, Metastasis, Mitotic Activity, Monoclonal Antibody, Necrosis, Neuron, Neurotransmitter, Oncology, Oncolytic Virotherapy, Prognosis, Radiotherapy, Stem Cell, Surgical…

Continue Reading Glioblastoma: Current Therapies and Recent Therapeutic Advances
Elfabrio Now Approved for Adults with Fabry Disease
https://pixabay.com/en/youth-active-jump-happy-sunrise-570881/

Elfabrio Now Approved for Adults with Fabry Disease

On May 10, 2023, reports EMPR, the U.S. FDA approved Elfabrio (pegunigalsidase alfa-iwxj) for adults who are living with Fabry disease. Developed by Protalix Biotherapeutics in conjunction with Chiesi Global…

Continue Reading Elfabrio Now Approved for Adults with Fabry Disease
Aggies’ Head Coach Jimbo Fisher Says Gene Therapy Could Cure Son’s Fanconi Anemia
https://pixabay.com/en/american-football-football-sports-1666276/

Aggies’ Head Coach Jimbo Fisher Says Gene Therapy Could Cure Son’s Fanconi Anemia

In 2014, head coach Jimbo Fisher led the Florida State Seminoles to win the BCS National Championship Game. He’s now head coach of the Texas A&M Aggies, recently deemed by…

Continue Reading Aggies’ Head Coach Jimbo Fisher Says Gene Therapy Could Cure Son’s Fanconi Anemia
“I Was Misdiagnosed with Every Disease That You Can Think of:” A Charcot-Marie-Tooth Disease Story
Author Lily Sander

“I Was Misdiagnosed with Every Disease That You Can Think of:” A Charcot-Marie-Tooth Disease Story

Written by Lily Sander By the time I was age four, I started experiencing unexplained symptoms such as severely turned in feet, which caused extreme pain and mobility issues. Terrified,…

Continue Reading “I Was Misdiagnosed with Every Disease That You Can Think of:” A Charcot-Marie-Tooth Disease Story
Rucosopasem Manganese Granted Orphan Drug Designation for Pancreatic Cancer
mohamed_hassan / Pixabay

Rucosopasem Manganese Granted Orphan Drug Designation for Pancreatic Cancer

  On May 18, 2023, Market Watch reported that rucosopasem manganese received Orphan Drug designation. Developed by clinical stage biopharmaceutical company Galera Therapeutics (“Galera”), rucosopasem manganese is largely being developed…

Continue Reading Rucosopasem Manganese Granted Orphan Drug Designation for Pancreatic Cancer
Hydroxyurea is Recommended for Children with Sickle Cell Anemia. So Why Does It Remain Underused?
source: pixabay.com

Hydroxyurea is Recommended for Children with Sickle Cell Anemia. So Why Does It Remain Underused?

In 2014, the National Heart, Lung, and Blood Institute released updated clinical guidelines in reference to the care of children with sickle cell anemia. The updated guidelines recommended the use…

Continue Reading Hydroxyurea is Recommended for Children with Sickle Cell Anemia. So Why Does It Remain Underused?
Damage from Cocaine Abuse can be Misdiagnosed as Granulomatosis with Polyangiitis
source: shutterstock.com

Damage from Cocaine Abuse can be Misdiagnosed as Granulomatosis with Polyangiitis

  The damage caused by cocaine can sometimes be misdiagnosed as a rare disease: granulomatosis with polyangiitis. Cocaine use has been increasing in America and the UK, resulting in serious…

Continue Reading Damage from Cocaine Abuse can be Misdiagnosed as Granulomatosis with Polyangiitis
Compassion Corner: Compassion Should be Reciprocal: The Rising Suicide Rate of Physicians and Nurses
source: shutterstock.com

Compassion Corner: Compassion Should be Reciprocal: The Rising Suicide Rate of Physicians and Nurses

Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…

Continue Reading Compassion Corner: Compassion Should be Reciprocal: The Rising Suicide Rate of Physicians and Nurses
OCU410ST Granted Orphan Drug Designation for ABCA4-Associated Retinopathies
source: pixabay.com

OCU410ST Granted Orphan Drug Designation for ABCA4-Associated Retinopathies

  ABCA4-associated retinopathies are a group of conditions that cause progressive macular degeneration and vision loss due to ABCA4 mutations. Stargardt disease, cone-rod dystrophy type 3 (CORD3), and retinitis pigmentosa 19…

Continue Reading OCU410ST Granted Orphan Drug Designation for ABCA4-Associated Retinopathies